Condition: Diabetes in Pregnancy · Gestational Diabetes · Sponsor: Rutgers, The State University of New Jersey
The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as long-acting insulin plus meal-time insulin? 2. Do babies born to mothers who take one dose of long-acting insulin have more complications after birth than babies born to mothers who take long-acting and meal-time insulin? Researchers will compare one dose of long-acting insulin per day to this plus three doses of short-acting insulin with each meal to see if blood sugars are controlled. Participants will send their blood sugar logs to the study staff weekly, instead of to their OB/GYN, for adjustments to their insulin dosing.
This description comes directly from the study's public registry record.
Morgan Dunn, MD · (732) 235-6632 · mcd189@rwjms.rutgers.edu
Emily Rosenfeld, DO · er720@rwjms.rutgers.edu
Always discuss trial participation with your own doctor first.
| Robert Wood Johnson Univeristy Hospital | New Brunswick, New Jersey, United States | Recruiting |
| Maternal-Fetal Medicine at NYU Langone Obstetrics & Gynecology Associates | New York, New York, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07171684